Searchable abstracts of presentations at key conferences in endocrinology

ea0028p145 | Neoplasia, cancer and late effects | SFEBES2012

Use of 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) in the diagnostic pathway for large adrenal lesions

Gunganah Kirun , Moyes Veronica , Druce Maralyn , Drake William , Akker Scott

Introduction: The investigation and management of large adrenal lesions varies widely. It is appropriate to have a low threshold for surgical removal of large adrenal lesions with the possible exception of stable adrenomyelipomata. 18F-FDG PET is increasingly used as an imaging technique to assess these lesions. We would like to highlight the potential benefits and pitfalls of using 18F-FDG PET as part of the diagnostic pathway.Method: Since 2008, 18F-FD...

ea0015oc17 | Tumours, diabetes, bone | SFEBES2008

Cinacalcet is an effective and well tolerated treatment for MEN1 associated primary hyperparathyroidism

Moyes Veronica , Alexandraki Krystallenia , Monson John , Akker Scott , Chew Shern

Cinacalcet is a calcimimetic agent licensed for the treatment of secondary hyperparathyroidism and parathyroid carcinoma. Multiple endocrine neoplasia type 1 (MEN1) patients may benefit considerably from cinacalcet. Affected patients have hyperplasia of multiple parathyroid glands, rather than a single resectable adenoma. Surgical cure requires removal of all parathyroid tissue, which is often unsuccessful, resulting in multiple neck explorations and hypoparathyroidism. Cinaca...